期刊文献+

新型乙酰胆碱酯酶抑制剂对阿尔茨海默病大鼠行为记忆的作用 被引量:5

Effect of novel AChE inhibitor on spatial learning and memory of Alzheimer rats
下载PDF
导出
摘要 目的探讨新型乙酰胆碱酯酶抑制剂(novel AChE inhibitor,NAI)对阿尔茨海默病(AD)大鼠空间记忆行为的影响,为AD病人的临床治疗提供可信的行为学资料.方法实验选用48只3~5月龄Wistar雄性大鼠,随机分为4组(n=12):NAI组、石杉碱甲(Hup) 组、单纯损伤(SO)组,空白对照组,将前3组大鼠切断穹隆-海马伞制作AD动物模型,然后分别进行Morris水迷宫实验.结果定位航行实验中,NAI组寻找水下平台的逃避潜伏期较SO组显著缩短(P<0.01).空间探索实验中,各象限游泳距离占总距离百分率和跨越各象限平台相应位置次数占总次数百分率,NAI组均较SO组明显增高 (P<0.01).结论 AD大鼠经过NAI治疗及水迷宫行为训练后,可显著改善其对空间学习记忆的能力,提示NAI对AD大鼠具有一定的治疗作用. Objective To investigate the effects of novel AChE inhibitor (NAI) on spatial learning and memory of Alzheimer disease (AD) rats and provide credible behavioural data for clinical treatment of AD. Methods 48 male Wistar rats aged 3 - 5 months were averagely randomly divided into NAI, huptrzin A ( Hup), simple-operated and control group, the rats in the former three groups were cut off fornix-fimbria hippocampus to make AD models. All groups were tested on Morris water maze test. Results The escape latency of NAI group was significantly shorter than that of SO group ( P 〈 0.01 ) in the place navigation test. The percentages of swim distance in the quadrant and times of crossing the platform of NAI group significantly increased than those in SO group ( P 〈 0.01 ) in spatial explore test. Conclusions NAI treatment and water maze training could promote the ability of spatial learning and memory of AD rats, which suggest that NAI should play a therapeutic role in AD.
出处 《中国老年学杂志》 CAS CSCD 北大核心 2005年第12期1488-1490,共3页 Chinese Journal of Gerontology
基金 国家自然科学基金资助项目(39970865)
关键词 胆碱酯酶抑制剂 水迷宫 AD大鼠 空间记忆 AChE inhibitor Water maze Alzheimer rats Spatial memory
  • 相关文献

参考文献4

二级参考文献24

  • 1Wang T, Tang X C. Reversal of scopolamine-induced deficits in radial maze performance by (-)-huperzine A: comparison with E2020 and tacrine [J]. Eur J Pharmacol, 1998,349(2-3):137-142.
  • 2Bejar C, Wang R H, Weinstock M. Effect of rivastigmine on scopolamine-induced memory impairment in rats [J]. Eur J Pharmacol, 1999,383(3):231-240.
  • 3Chen Z, Kamei C. Facilitating effects of histamine on spatial memory deficit induced by scopolamine inrats [J]. Acta Pharmacol Sin, 2000,21(9):814-818.
  • 4Benzi G, Moretti A. Is there a rational for the use of acetylcholinesterase inhibitors in the therapy of Alzheimer's disease [J]? Eur J Pharmacol, 1998,346(1):1-13.
  • 5Tang X C, Han Y F. Pharmacological profole of huperzine A, a novel acetylcholinesterase inhibitor from Chinese Herb [J]. CNS Drug Rev, 1999,5(3):281-300.
  • 6Chen Z. Effect of histamine H3-receptor antagonist clo-benpropit on spatial memory of radial maze performance in rats [J]. Acta Pharmacol Sin, 2000,21(10):905-910.
  • 7Miyamoto M, Takahashi H, Kato K, et al. Effects of 3-[1-(phenylmethyl)-4-piperidinyl]-1(2,3,4,5-tetrahydro-1H-1-benzazepin-8-yl)-1-propanone fumarate (TAK-147), a novel acetylcholinesterase inhibitor, on impaired learning and memory in animal models [J]. J Pharmacol Exp Ther, 1996,277(3):1292-1304.
  • 8Kato K, Hayako H, Ishihara Y, et al. TAK-147, an acetylcholinesterase inhibitor, increases choline acetyltransferase activity in cultured rat septal cholinergic neurons [J]. Neuroscience Lett, 1999,260(1):5-8.
  • 9Nakagawa Y, Takashima T. The GABAB receptor antagonist CGP36742 attenuates the baclofen-and scopolamine-induced deficit in Morris water maze task in rats [J]. Brain Research, 1997,766(1-2):101-106.
  • 10Braida D, Paladini E, Griffini P, et al. An inverted U-shaped curve for heptylphysostigmine on radial maze performance in rats: comparison with other cholines-terase inhibitors [J]. Eur J Pharmacol, 1996,302(1-3):13-20.

共引文献19

同被引文献32

引证文献5

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部